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CTOS Meeting Program
Thursday, November 1, 2001
1:00–5:00 p.m. Registration, Set Up Posters
6:00–7:00 p.m. Welcome Reception
Friday, November 2, 2001
7:00 a.m. Registration, Breakfast for meeting attendees
7:00 a.m. Executive Committee Meeting
8:00 a.m. Welcome, Opening Announcements: Jaap Verweij, CTOS President
8:15 a.m. PEDIATRIC SARCOMAS: Chairmen: Lee Helman (USA) & Herbert Jurgens (Germany)
8:15 a.m. Herbert Jurgens: Pediatric sarcoma: state of the art
8:30 a.m. Tim Triche: From gene activation to signal transduction treatment
8:45 a.m. Lenny Wexler: Irinotecan in refractory RMS
9:00 a.m. Peter  Anderson:  Inhalation  GMCSF  for  treatment  of  pulmonary
metastases
9:15 a.m. Abstract number 40 Her-2/NEU staining in osteosarcoma: association
with  increased risk of  metastatis—Holly  Zhou,  Rob Goldsby, R. Lor
Randall,  Lynn  Smith,  Cheryl  M.  Coffin  Departments  of  Pathology,
Pediatrics, Orthopedics, and Radiation Oncology, University of Utah
9:30 a.m. Summary and Panel Discussion: Where do we go from here? Lee Helman
10.00 a.m. Coffee Break, Poster Viewing
10:15 a.m. BONE TUMORS: Chairmen: Peter Choong (Australia) & Thor Alvegard (Sweden)
10:15 a.m. Linda Granowetter: US Ewing’s sarcoma randomized study of higher dose
therapy
10:30 a.m. Kristy Weber: Implications and management of local relapse in Ewing’s
sarcoma
10:45 a.m. Peter  Choong:  The  role  of  functional  nuclear  scanning  in  sarcoma
management
11:00 a.m. Sigbjörn Smeland: An overview of treatments results in osteosarcoma: is
there a need for a global collaboration?
11:15 a.m. Abstract number 87 Reconstruction of the pelvis following resection of
tumors about the acetabulum—R. L. Satcher, Jr., R. J. O’Donnell, J. O.
Johnston, University of California, San Francisco
11:30 a.m. Abstract  number  22  Curative  treatment  and effective  palliation  with
hemipelvectomy—A useful operation: modern concepts based on 20 years
of experience—James C Wittig, Jacob Bickels, Felasfa Wodajo, Kristen L.
Kellar-Graney,  Yehuda  Kollender,  Isaac  Meller,  Martin  M  Malawer
Division  of  Orthopedic  Oncology,  Washington  Cancer  Institute  and
National Unit of Orthopedic Oncology, Tel-Aviv Sourasky Medical Center
11:45 a.m. Abstract number 16 (Young Investigator Award Winner) Bugged
out? Infection and endoprosthetic replacements—Lee M Jeys, Raj Suneja,
Vishnu Prasad, Robert Grimer, Simon R Carter, Roger Tillman Royal
Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital
12:00 p.m Summary and Panel Discussion: Where do we go from here? Thor Alvegard
12:15 p.m. Buffet Lunch, Poster Viewing
12:15 p.m Board of Directors Meeting
1:15 p.m. Jaap Verweij, CTOS President: Presentations of Two Young Investigator Awards
(Lee M Jeys, Jonathan C Trent)S6 CTOS  abstracts
1:30 p.m. SOFT TISSUE SARCOMAS: Chairmen: Jean-Yves Blay (France) & Brian O’Sullivan
(Canada)
1:30 p.m. Pancras Hogendoorn: Grading of soft tissue tumours
1:45 p.m. Peter Pisters: Preoperative chemoradiotherapy for locally advanced soft
tissue sarcomas
2:00 p.m. Brian O’Sullivan: The advantage of new radiotherapy technologies in the
management of soft tisssue sarcoma
2:15 p.m. Controversy  session:  polychemotherapy  vs.  monochemotherapy  in
advanced sarcomas:
2:15 p.m. pro: Bob Benjamin
2:30 p.m. contra: Jaap Verweij
2:45 p.m. Discussion
3:00 p.m. Abstract  number  56  Margin  width  has  prognostic  significance  for
extremity  and  truncal  sarcoma—Mark  D.McKee,  Dong  Feng  Liu,
Deborah Driscoll, John J. Brooks, John F. Gibbs, William G. Kraybill
Roswell Park Cancer Institute
3:15 p.m. Summary & Panel Discussion: Where do we go from here? Jean Yves Blay
3:45 p.m. Coffee Break, Poster Viewing
4:00 p.m. BASIC SCIENCE/BIOLOGY: Jonathan Fletcher (USA) & Junya Toguchida (Japan)
4:00 p.m. Marc Ladanyi: Alveolar soft part sarcoma oncogene
4:20 p.m. Charlie Roberts: SNF5/INI1 haploinsufficiency predisposes to rhabdoid
tumors in mice
4:40 p.m. Paul  Meltzer:  Clinical  and  biological  applications  of  sarcoma  gene
expression profiling
5:00 p.m. Abstract number 106 Gene-expression profiles in chondrosarcomas and
chordomas—Thomas F. DeLaney, Brian Seed, Ramnik Xavier, Andrew
L. Rosenberg, G. Petur Nielsen, Francis J. Hornicek, Norbert J. Liebsch,
John E. Munzenrider, Herman D. Suit, Massachusetts General Hospital
5:15 p.m. Summary and Panel discussion: Jonathan Fletcher & Junya Toguchida
6:00–6.30 p.m. Members’ Business Meeting
7:15 p.m CTOS Reception and Dinner Banquet
Saturday, November 3, 2001
7:00 a.m. Registration, Breakfast for meeting attendees
8:00 a.m. NINA AXELRAD  KEYNOTE  LECTURE  (Supported by  the Nina  Axelrod Sarcoma
Fund):
Allan van Oosterom (Leuven, Belgium): Systemic treatment of advanced soft tissue sarco-
mas is not uniform any longer; Glivec as a paradigm.
9:00 a.m. IMATINIB MESYLATE (DEVELOPED AS STI-571): George Demitri (USA) & Jaap
Verweij (Netherlands)
9:00 p.m. Brian Rubin: Biology of GISTs
9:15 p.m. George Demitri: The USA experience
9:30 p.m. Jaap Verweij: The EORTC phase 2 study
9:45 p.m. Abstract  number  131  (Young  Investigator  Award  Winner)
Inhibition  of  PDGF  receptor  tyrosine  kinase  in  human  soft-tissue
sarcoma—Jonathan C. Trent, Jonathan Hannay, Lan Li, Shreyaskumar
Patel,  Robert  S.  Benjamin,  Raphael  E.  Pollock,  Di-Hua  Yu  The
University of Texas, M. D. Anderson Cancer Center
10:00 p.m. Panel Discussion: Where do we go from here? George Demitri & Jaap
VerweijCTOS  abstracts S7
10:15 a.m. Coffee Break, Poster Viewing
10:30 a.m. Workshop: Genetics of Sarcoma: Jonathan Fletcher (USA) & Lee Helman (USA)
10:30 a.m. Paola Dal Cin: Novel cytogenetic mechanisms in mesenchymal tumors
10:50 a.m. Marc Ladanyi: Specificity and clinical correlations for SYT-SSX
11:10 a.m. Abstract number 130 Expression profiling of osteosarcoma biopsies and
metastases  with  CDNA  microarrays—Luca  Sangiorgi,  Giuliana
Alessandra Gobbi, Enrico Lucarelli, Francesca Scrimieri, Piero Picci, Paul
Meltzer,  Lab.  Oncology  Research,  Rizzoli  Orthopedic  Institute,  and
Section  of  Molecular  Genetics,  Cancer  Genetics  Branch,  National
Human Genome Research Institute, National Institutes of Health
11:25 a.m. Summary and Panel Discussion: Where do we go from here? Jonathan
Fletcher & Lee Helman
11:45 a.m. Buffet Lunch, Poster Viewing
12:45 p.m. COOPERATIVE  GROUP  RESEARCH:  Jaap  Verweij  (The  Netherlands)  &  Karen
Antman (USA)
1:45 p.m. Mini Symposium: STAGING, RESPONSE ASSESSMENT & FOLLOW-UP: Peter
Hohenberger (Germany) & Ian Judson (UK)
1:45 p.m. Jan Bloem: Staging and dynamic contrast enhanced MRI for response
assessment
2:00 p.m. Peter Hohenberger: 31P magnetic resonance spectroscopy (31P-MRS)
for  non-invasive  assessment of  pathohistologic  tumor  response of  soft
tissue sarcoma
2:15 p.m. A.  Kevin  Raymond:  Pathohistological  response  assessment  following
systemic chemotherapy for sarcomas
2:30 p.m. Summary and Panel Discussion: Where do we go from here? Ian Judson
2:45 p.m. CASE DISCUSSIONS: ANGIOSARCOMAS Paolo Casali (Italy)
 Medical Oncology: Paolo Casali
 Pathology: John Brooks
 Surgery: Sylvie Bonvalot
 Radiotherapy: Kirsten Sundby Hall
3:45 p.m. Adjournment